Recruiting

DFC 004

Sponsor:

University of Michigan

Code:

NCT06104969

Conditions

Diabetic Foot Ulcer

Diabetic Foot

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinical trials of wound healing interventions

Conditions

Diabetic Foot Ulcer

Diabetic Foot

Diabetes

Study ID

NCT06104969

Start date

Jun 15, 2023

Status verified date

Sep, 2026

Completion date

Jun 15, 2028

Anticipated

Primary completion date

Jun 15, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Provision of signed and dated informed consent form.
2. Age 18 years or older.
3. Clinically diagnosed with diabetes or meeting the American Diabetes Association (ADA) criteria. \[ADA Standards of Clinical Care Diabetes Care 2022, Suppl 1\]
4. Open foot ulcer, defined as an open wound from malleolus down. This includes post-surgical wounds within this area left open to heal by secondary intention. In case of multiple ulcers, the largest ulcer will be considered the study index DFU.
5. Agreement to adhere to protocol visits and provide all required biospecimens and clinical data.

Exclusion Criteria:

1. Participation in an interventional clinical trial for DFU within 1 month of Visit 1.
2. Currently receiving radiation to target area or chemotherapy.
3. Gangrene in any portion of the foot with the index ulcer.
4. Planned revascularization or under evaluation for revascularization of the index limb for advanced ischemia within next 4 weeks of Week 0.
5. Severe limb ischemia (SVS WIfl Ischemia grade 3).
6. Any concomitant medical or psychiatric condition that, in the opinion of the investigator(s), would compromise the participant's ability to safely complete the study.

Study Design

Enrollment

5000 participants

Anticipated

Interventions and Outcome Measures

Arms

Diabetic Foot Ulcer

Adult individuals with at least one diabetic foot ulcer who meet inclusion/exclusion criteria

Primary outcome measure

  • Wound Healing [ Time Frame: 52 Weeks ]
  • DFU Infections [ Time Frame: 52 Weeks ]
  • Amputations [ Time Frame: 52 Weeks ]
  • Prediction Performance [ Time Frame: 52 Weeks ]
  • Biospecimens Count [ Time Frame: 52 Weeks ]
  • Biospecimen Quality [ Time Frame: 52 Weeks ]
  • Standard of Care Prescription by Site [ Time Frame: 52 Weeks ]
  • Standard of Care Adherence [ Time Frame: 52 Weeks ]

Central Contacts and Locations

Locations

University of Arizona College of Medicine

Recruiting

Tucson, Arizona, United States, 85724

Contacts

Principal Investigator:

Geoffrey Gurtner, MD

University of California - San Francisco

Recruiting

San Francisco, California, United States, 94143

Contacts

Principal Investigator:

Michael Conte, MD

Emory University School of Medicine

Recruiting

Atlanta, Georgia, United States, 30303

Contacts

Principal Investigator:

Marcos Schechter

Beth Israel Deaconess Medical Center

Recruiting

Boston, Massachusetts, United States, 02215

Contacts

Principal Investigator:

Aristidis Veves, MD

University of Michigan

Recruiting

Ann Arbor, Michigan, United States, 48109

Contacts

Principal Investigator:

Crystal Holmes, DPM

Northwell Health

Recruiting

Lake Success, New York, United States, 11042

Contacts

Principal Investigator:

Alisha Oropallo, MD

University of Pittsburgh

Recruiting

Pittsburgh, Pennsylvania, United States, 15219

Contacts

Principal Investigator:

Chanden Sen, PhD

University of Texas Health San Antonio

Recruiting

San Antonio, Texas, United States, 78229

Contacts

Principal Investigator:

Lawrence Lavery

More Information

Sponsor

University of Michigan

Last update posted

Sep 9, 2026

Last verified

Sep, 2026

Keywords

  • diabetic foot ulcer
  • Diabetic Foot Consortium

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Michigan on 2026-09-09.